Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...